Meta Pixel

News and Announcements

Additional Placement Raises $1.0 million for Prescient Therapeutics

  • Published November 26, 2015 11:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

24th November 2015, ASX Announcement

Cancer drug development company Prescient Therapeutics Limited (ASX: PTX) (‘Prescient’, ‘PTX’ or ‘the Company’) advises that following the oversubscribed Share Purchase Plan (‘SPP’), the Company has subsequently raised approximately $1.0million. The Company is completing an additional top up placement of approximately 19.3 million fully paid ordinary shares at $0.054 (5.4 cents) per share, which is the same price as the SPP issue price. Together with the recently completed SPP, PTX has raised approximately $2.0 million, exceeding the Company’s expectations.

PTX expects these funds to provide for efforts to achieve multiple milestones across its clinical programs over the next 12 to 18 months.

To read the full announcement, please click here. 

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now